Hycor Biomedical

From Wikipedia, the free encyclopedia

Template:Short description

Page Module:Message box/ambox.css has no content.

Page Module:Infobox/styles.css has no content.Page Template:Infobox company/styles.css has no content.

HYCOR Biomedical
Company type
Headquarters
ISINScript error: No such module "WikidataIB".
IndustryScript error: No such module "WikidataIB".
PredecessorScript error: No such module "WikidataIB".
IncorporatedScript error: No such module "WikidataIB".
FoundedScript error: No such module "WikidataIB".
FounderScript error: No such module "WikidataIB".
DefunctScript error: No such module "WikidataIB".
SuccessorScript error: No such module "WikidataIB".
Headquarters
Area served
Worldwide
RevenueScript error: No such module "WikidataIB".
Script error: No such module "WikidataIB".
Script error: No such module "WikidataIB".
Total assetsScript error: No such module "WikidataIB".
Number of employees
Script error: No such module "WikidataIB".
ParentScript error: No such module "WikidataIB".
Websitehttps://www.hycorbiomedical.com/

Script error: No such module "Check for conflicting parameters".Script error: No such module "Check for deprecated parameters".

HYCOR Biomedical is an American corporation specializing in the manufacture and supply of in vitro diagnostic products for blood testing for allergies. The company is headquartered in Garden Grove, California, with offices in Amsterdam, Netherlands.

The company was acquired by Linden Capital Partners in early 2010.[1]

Products and services

HYCOR Biomedical mainly produces tests and equipment relating to Allergy.[2]

Current equipment released by HYCOR includes the fully-automated NOVEOS Immunoanalyzer that uses only 4 microliters of sample per test, paramagnetic microparticles as a solid phase, chemiluminescence and fluorescence methodology for high sensitivity, and liquid ready-to-use reagents.

The HYTEC 288 Plus EIA system continues to serve laboratories around the world. The NOVEOS system is the first BIG change in routine allergy testing in over 20 years, helping reduce interference issues and the amount of sample needed to perform testing.

Currently[when?], HYCOR Biomedical has an estimated 5% market share[3] in allergy testing, second to Thermo Fisher Scientific's ImmunoCAP and Phadia instrumentation.

Allergy testing

The more common method for allergy testing, called skin prick testing, relies on examining a patient's reaction to the exposed allergen,[4] and in some cases, invokes large systemic reactions.[5] With a growing need for testing younger patients[6] without putting them at risk, in vitro testing has become an increasingly more viable alternative.

References

Page Template:Reflist/styles.css has no content.

  1. ^ Page Module:Citation/CS1/styles.css has no content."Linden Acquires Hycor Biomedical Business from Agilent Technologies". www.investor.agilent.com. Retrieved 2026-05-20.
  2. ^ Page Module:Citation/CS1/styles.css has no content."Products - HYCOR Biomedical". www.hycorbiomedical.com/.
  3. ^ [1] Script error: No such module "webarchive".
  4. ^ Page Module:Citation/CS1/styles.css has no content."Find the Source of Allergies". WebMD.
  5. ^ Page Module:Citation/CS1/styles.css has no content.Liccardi, G.; D'Amato, G.; Canonica, G. Walter; Salzillo, A.; Piccolo, A.; Passalacqua, G. (2006). "Systemic reactions from skin testing: literature review". Journal of Investigational Allergology & Clinical Immunology. 16 (2): 75–78. ISSN 1018-9068. PMID 16689179.
  6. ^ Page Module:Citation/CS1/styles.css has no content.Burks, Wesley (April 1, 2003). "Peanut allergy: a growing phenomenon". The Journal of Clinical Investigation. 111 (7): 950–952. doi:10.1172/JCI18233. PMC 152593. PMID 12671042.


Lua error in package.lua at line 80: module 'Module:Navbar/configuration' not found.